Review decisions

Showing 100 results of 287 total
Summary Safety Review - Cellex Photopheresis System and Venous Thromboembolism & Pulmonary Embolism
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00222
Issued / Original Publication Date: 2019-05-03
Summary Safety Review - Intragastric balloons - Assessing the potential risk of inflamed pancreas, developing a hole (perforation) in the esophagus and stomach, and unexpected balloon enlargement (overinflation)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00221
Issued / Original Publication Date: 2019-04-17
Summary Safety Review - Opsumit (macitentan) - Assessing the potential risk of liver injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00220
Issued / Original Publication Date: 2019-03-01
Summary Safety Review - Gilenya (fingolimod) - Assessing the potential risk of worsening multiple sclerosis symptoms after product withdrawal (rebound effect)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00219
Issued / Original Publication Date: 2019-02-28
Summary Safety Review - Proscar and Propecia (finasteride) - Assessing the potential risk of suicidal thoughts and/or behaviour (suicidal ideation)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00218
Issued / Original Publication Date: 2019-02-26
Summary Safety Review - Ferriprox (deferiprone) - Assessing the potential risk of brain and nervous system (neurological) disorders in children
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00217
Issued / Original Publication Date: 2019-02-25
Summary Safety Review - Opioid-containing cough and cold products - Assessing the potential risk of opioid use disorder and related harms in children and adolescents
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00216
Issued / Original Publication Date: 2019-02-18
Summary Safety Review - Hydrochlorothiazide - Assessing the potential risk of non-melanoma skin cancer
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00215
Issued / Original Publication Date: 2019-01-30
Summary Safety Review - Sulfamethoxazole containing products - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00214
Issued / Original Publication Date: 2019-01-07
Summary Safety Review - Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR TKIs) - Assessing the potential risk of abnormal structural changes of the artery walls including rupture (Artery Dissections and Artery Aneurysms)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00213
Issued / Original Publication Date: 2018-12-03

Displaying 91 - 100 of 287 | Page 10 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: